CHATHAM THERAPEUTICS
Chatham Therapeutics LLC operates in the biotechnology sector. The company was formerly known as VECTORRX INC. The company was incorporated in 2010 and is based in Chapel Hill, North Carolina.
CHATHAM THERAPEUTICS
Industry:
Biotechnology Medical
Founded:
2010-01-01
Address:
Chapel Hill, North Carolina, United States
Country:
United States
Total Employee:
11+
Status:
Active
Total Funding:
201 K USD
Similar Organizations
Cytori Therapeutics
Cytori Therapeutics engages in the development of autologous cell therapies.
Primrose Therapeutics
Primrose Therapeutics is engaged in the development of treatments for polycystic kidney disease.
Founder
More informations about "Chatham Therapeutics"
Baxter to Acquire Chatham Therapeutics
Apr 2, 2014 DEERFIELD, Ill. and CHAPEL HILL, NC, April 2, 2014 - Baxter International Inc. (NYSE:BAX) and Chatham Therapeutics, LLC, today announced that Baxter has agreed to …See details»
Chatham Therapeutics 2025 Company Profile: Valuation, Investors ...
The current valuation of Chatham Therapeutics is . What is Chatham Therapeutics’s current revenue? The current revenue for Chatham Therapeutics is . How much funding has Chatham …See details»
Baxter snaps up its hemophilia partner on the verge of a biotech ...
Apr 2, 2014 Baxter is buying out collaborator Chatham Therapeutics for $70 million, planning to absorb the gene therapy specialist into its growing hemophilia R&D operation as it prepares to …See details»
Baxter to Acquire Chatham Therapeutics - AskBio
The integration of Chatham’s next-generation technology and expertise, along with Baxter’s global marketing and distribution presence, is a combination we anticipate will support efficient …See details»
Co-Founder - Chatham Therapeutics, LLC - LinkedIn
Biopharma Executive · Experience: Chatham Therapeutics, LLC · Location: Truckee · 225 connections on LinkedIn. View Mr. Jade Samulski, MPM’s profile on LinkedIn, a professional …See details»
Chatham Therapeutics - Funding, Financials, Valuation & Investors
Chatham Therapeutics is engaged in the development of gene-based therapy technologies focused on hemophilia.See details»
Chatham Therapeutics LLC - Drug pipelines, Patents, Clinical trials ...
North Carolina, United States | 10-50. Last update 23 Jan 2025See details»
CHATHAM THERAPEUTICS LLC - HIPAASpace
CHATHAM THERAPEUTICS LLC BUSINESS ADDRESS EIN 273755577 An Employer Identification Number (EIN) is also known as a Federal Tax Identification Number, and is used …See details»
Baxter Acquires Chatham for $70M+, Boosting Its Hemophilia …
Apr 2, 2014 Less than a week after disclosing plans to split up by spinning out its biopharma business, Baxter International plans to bulk up that spinout by acquiring Chatham …See details»
Baxter International Inc. completed the acquisition of membership ...
Apr 30, 2014 Baxter International Inc. (NYSE:BAX) agreed to acquire membership interests of Chatham Therapeutics, LLC for $630 million on April 2, 2014. As per the terms of the deal, …See details»
Baxter to Acquire Chatham Therapeutics
Apr 2, 2014 Chatham Therapeutics, LLC (Chatham) is a privately held clinical development-stage biotechnology company engaged in the development of novel, gene therapy-mediated …See details»
Baxter Acquires Biotech Co for $70M | Pharma Manufacturing
Apr 3, 2014 Baxter International has agreed to acquire privately held Chatham Therapeutics for an initial payment of $70 million,See details»
Baxter - Baxter Announces Collaboration with Chatham …
DEERFIELD, Ill., June 4, 2012 - Baxter International Inc. (NYSE:BAX) today announced that it has entered into an exclusive global agreement with Chatham Therapeutics, LLC, an affiliate …See details»
Chatham Therapeutics - Crunchbase
Chatham Therapeutics is engaged in the development of gene-based therapy technologies focused on hemophilia.See details»
WIB-National: FemTech and Women's Health – Capitalizing on ...
Nov 12, 2024 Additionally, she is a Managing Director at Golden Seeds, an angel investment organization focusing on funding early-stage companies led by women; she co-leads the …See details»
Baxter Announces Collaboration with Chatham Therapeutics for …
DEERFIELD, Ill.--(BUSINESS WIRE)-- Baxter International Inc. (BAX) today announced that it has entered into an exclusive global agreement with Chatham Therapeutics, LLC, an affiliate …See details»
Baxter and Chatham Partner to Develop Hemophilia Treatments
In June, Baxter International Inc., announced that it has entered into an exclusive global agreement with Chatham Therapeutics, LLC, an affiliate of Asklepios BioPharmaceutical, Inc. …See details»
R. Jude Samulski - President, Chief Scientific Officer ... - Crunchbase
Richard Samulski, Ph.D. serves as the President of Chatham Therapeutics LLC. Samulski has been Scientific Co-Founder of Asklepios Biopharmaceutical, Inc. since 2003 and served as its …See details»
Baxter Pursues Haemophilia B Gene Therapy with Chatham …
Baxter International has entered into an exclusive global development and commercialisation agreement with Chatham Therapeutics, an affiliate of Asklepios BioPharmaceutical, for …See details»
Federal government announces support for cutting-edge, AI- and …
3 days ago Since March 2020, over $2.3 billion has been invested to rebuild Canada’s vaccines, therapeutics and biomanufacturing capacity across our country. Today, the Honourable Anita …See details»